The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

A landmark deal aims to end the pricing games that grossly inflate what you pay at the pharmacy.

A decision last year by a global health company opened a chasm that still separates thousands of patients from a community ...

Regeneron Pharmaceuticals and Sanofi will lower the price of their cholesterol drug Praluent by up to $9,500 annually for Express Scripts customers. In return, Express Scripts will grant the ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...

Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles prescription drug ...

The nation's largest pharmacy benefit manager will soon limit the number and strength of opioid drugs prescribed to first-time users as part of a wide-ranging effort to curb an epidemic affecting ...

The lawsuit says Express Scripts and its affiliated organizations colluded with opioid manufacturers in deceptive marketing schemes to increase sales of the addictive drugs. Kentucky's attorney ...

A group of former Wells Fargo & Co. employees are appealing to the US Court of Appeals for the Eighth Circuit after a federal judge in Minnesota dismissed their lawsuit challenging prescription drug ...

LOS ANGELES (Reuters) - Express Scripts Holding Co , one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc , but exclude a rival medication ...

Benefits-eligible faculty and staff who are registered with Express Scripts (online or via the mobile app) soon will receive an email alerting them to the improved features and functionality of the ...